Okta Headed For Another Stock Boost From Quiet Period Expiration
Apr 27, 2017Jeremy Parkinson0
Event Overview The quiet period will expire for Okta (Nasdaq:OKTA), on May 2, 2015. On that date, restrictions preventing underwriters from recommending or reporting on the deal will be lifted. Underwriters tend to release reports as soon as restrictions are lifted and these reports most often are positive. Our firm has studied price movement around […]
It’s Different This Time…
Apr 27, 2017Jeremy Parkinson0
Just recently, Wealth Management had an interesting interview with Jeremy Grantham in which Jeremy suggests the “rules have changed” for value investors. To wit: “The market was extremely well-behaved from 1935 until 2000. It was an orderly world in which to be a value manager: there was mean reversion. If a value manager was patient, he was in heaven. The market outperformed when […]
Liquidity: The Most Important Fundamental
Apr 27, 2017Jeremy Parkinson0
I’m sure you’ve heard analysts, financial pundits, and other babbling heads yabber on and on about how these markets don’t reflect the “fundamentals”. They’ve ranted non-stop about how the fundamentals prove that a bear market is around the corner. They’ve raved about valuations being stretched and how stocks will collapse any day now… If you’ve been taking investment advice […]
Stocks Dazed After Trump NAFTA Flop, Tax Plan Disappointment; ECB Looms
Apr 27, 2017Jeremy Parkinson0
European shares are lower, pressured by disappointing results by Deutsche Bank and ending a six-session gain, as Asian equities and S&P futures were little changed after a record-setting rally in world stocks which pushed the MSCI World index to over $50 trillion yesterday, fizzled after Trump released unconvincing tax cut plans prompting traders to “sell […]
Premarket Biotech Digest – ANTM May Increase Premium, IPXL Receives FDA Approval, ZTS Receives EC Nod
Apr 27, 2017Jeremy Parkinson0
Top Pick of the Day: MNOV MediciNova Inc. (MNOV) announced that it has received positive preliminary results from a six-month open-label extension period evaluating MN-166 (ibudilast) in patients with amyotrophic lateral sclerosis. ALS patients who completed both the six-month treatment period in the Phase 2 clinical trial and the six-month open-label extension period (n=31) experienced significantly higher […]
Another Rate Hike By June?
Apr 27, 2017Jeremy Parkinson0
The probability of another rate hike for the Fed’s policy meeting in June continues to tick higher, according to futures data, but no change in rates is expected at next week’s FOMC meeting. Fed funds futures are currently pricing in a 75% probability that the central bank will lift the Fed funds futures on June […]
GBP/USD Moves Closer To The Psychological Top At 1.3000
Apr 27, 2017Jeremy Parkinson0
At the beginning of Thursday trading, the GBP/USD pair shot up achieving strong gains up to 1.2917, before settling around 1.2897 at the time of writing. Amid continued bullish momentum for the pair since the surprising announcement by the UK P.M of the early elections to support the stability in the country in the post […]
Trump-Xi Summit Sets Positive Tone For U.S.- China Relations
Apr 27, 2017Jeremy Parkinson0
Concerns over an imminent U.S.-China trade war quickly evaporated this month after an executive meeting between Donald Trump and Xi Jinping ended on friendly terms, setting the stage for a potentially amicable relationship between the world’s greatest economic powers. The U.S. president hosted his Chinese counterpart over a two-day summit in Mar-a-Lago April 6-7, where […]
Deutsche Bank Tumbles Most In 5 Weeks After Earnings Disappoint Across The Board
Apr 27, 2017Jeremy Parkinson0
On the surface, Deutsche Bank’s results this morning came in better than expected with first quarter earnings more than doubling as Germany’s biggest bank benefited from a pick-up in market activity at the start of the year. In the three months to March, Deutsche managed to make a net profit of €575m, more than double […]
Euro May Fall As Dovish Draghi Sets Stage For ECB QE Change
Apr 27, 2017Jeremy Parkinson0
A monetary policy announcement from the European Central Bank headlines the economic calendar. Changes aside from the implementing the previously announced intent to reduce the size of monthly asset purchases – down to €60 billion from €80 billion previously – are not expected. When that change was unveiled some months ago, it was coupled with an extension […]